1. Academic Validation
  2. Exploiting Ultrashort α,β-Peptides in the Colloidal Stabilization of Gold Nanoparticles

Exploiting Ultrashort α,β-Peptides in the Colloidal Stabilization of Gold Nanoparticles

  • Langmuir. 2021 Sep 28;37(38):11365-11373. doi: 10.1021/acs.langmuir.1c01981.
Raffaella Bucci 1 Daniela Maggioni 2 Silvia Locarno 3 Anna Maria Ferretti 4 Maria Luisa Gelmi 1 Sara Pellegrino 1
Affiliations

Affiliations

  • 1 DISFARM-Dipartimento di Scienze Farmaceutiche, Sezione Chimica Generale e Organica "A. Marchesini", Università degli Studi di Milano, Via Venezian 21, 20133 Milano, Italy.
  • 2 Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy.
  • 3 Dipartimento di Fisica "Aldo Pontremoli", Università degli Studi di Milano, Via Celoria 16, 20133 Milano, Italy.
  • 4 Istituto di Scienze e Tecnologie Chimiche ″Giulio Natta″, Consiglio Nazionale Delle Ricerche (SCITEC-CNR), Via G. Fantoli 16/15, 20138 Milano, Italy.
Abstract

Colloidal gold nanoparticles (GNPs) have found wide-ranging applications in nanomedicine due to their unique optical properties, ease of preparation, and functionalization. To avoid the formation of GNP aggregates in the physiological environment, molecules such as lipids, Polysaccharides, or Polymers are employed as GNP coatings. Here, we present the colloidal stabilization of GNPs using ultrashort α,β-peptides containing the repeating unit of a diaryl β2,3-amino acid and characterized by an extended conformation. Differently functionalized GNPs have been characterized by ultraviolet, dynamic light scattering, and transmission electron microscopy analysis, allowing us to define the best candidate that inhibits the aggregation of GNPs not only in water but also in mouse serum. In particular, a short tripeptide was found to be able to stabilize GNPs in physiological media over 3 months. This new system has been further capped with albumin, obtaining a material with even more colloidal stability and ability to prevent the formation of a thick protein corona in physiological media.

Figures
Products